Gene Expression Analysis Market Share, Size, Trends, Industry Analysis Report, By Product & Service (Reagents & Consumables, Instruments, Service); By Application; By End User; By Region; Segment Forecast, 2024 - 2032

Gene Expression Analysis Market Share, Size, Trends, Industry Analysis Report, By Product & Service (Reagents & Consumables, Instruments, Service); By Application; By End User; By Region; Segment Forecast, 2024 - 2032

The global gene expression analysis market size is expected to reach USD 7.32 Billion by 2032, according to a new study by Polaris Market Research. The report “Gene Expression Analysis Market Share, Size, Trends, Industry Analysis Report, By Product & Service (Reagents & Consumables, Instruments, Service); By Application; By End User; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global market for gene expression analysis is witnessing growth, driven by the increasing demand for personalized medicine and advancements in genomics and proteomics. The biotechnology and biopharmaceutical industries are also contributing to this growth. The rising prevalence of cancer and genetic disorders has led to a greater need for effective diagnostic tools. The market is experiencing a major shift towards next-generation sequencing (NGS) technologies that allow the simultaneous analysis of millions of DNA sequences in a single run, making it faster and more cost-effective than traditional methods. As a result, NGS technologies are being increasingly adopted in research and clinical settings, driving the growth of the gene expression analysis market.

However, the market is facing significant challenges due to the high costs associated with gene expression analysis techniques, particularly NGS technologies. This can hinder researchers and clinicians from accessing these powerful tools. Despite these challenges, the outlook for the market remains positive, as there is a growing need for personalized medicine and the development of novel and innovative technologies.

Technological advancements in sequencing have enabled the analysis of genomic data on a large scale, further fueling the demand for gene expression analysis tools and services. The market for gene expression analysis is robust, with opportunities for both established players and emerging start-ups. The focus on precision medicine and the development of novel therapeutics is expected to drive further growth in this market.

Gene Expression Analysis Market Report Highlights

• In 2023, the global market was dominated by the reagents and consumables segment. This was largely attributed to the fact that reagents and consumables form an integral part of several gene expression analysis techniques such as PCR, microarray analysis, and next-generation sequencing.
• The drug discovery and development industry is poised for substantial growth due to the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders. This has led to a demand for novel and effective drugs to counter these ailments.
• The market saw the North American region emerge as the frontrunner in 2023. This was largely due to the region's superior technological infrastructure, significant investments in research and development, and thriving biotechnology sector, which enabled the region to establish a dominant position in the market.
• The global key market players include Agilent Technologies, Inc, BGI, Bio-Rad Laboratories, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, Illumina, Inc., LGC Biosearch Technologies, Oxford Nanopore Technologies plc, PacBio, Promega Corporation, QIAGEN, Standard BioTools, Thermo Fisher Scientific Inc., among others.

Polaris Market Research has segmented the gene expression analysis market report based on product & service, application, end user, and region:

Gene Expression Analysis, Product & Service Outlook (Revenue - USD Billion, 2019 - 2032)

• Reagents & Consumables

- Assays & kits

- Enzymes

- DNA chips

- Others

• Instruments

- PCR

- NGS

- DNA Microarrays

- Others

• Service

- Gene Expression Analysis

- RNA Sequencing Services

- Other Services

- Bioinformatics Solutions

Gene Expression Analysis, Application Outlook (Revenue - USD Billion, 2019 - 2032)

• Drug Discovery & Development
• Clinical Diagnostics
• Others

Gene Expression Analysis, End User Outlook (Revenue - USD Billion, 2019 - 2032)

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others

Gene Expression Analysis, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America

- U.S.

- Canada

• Europe

- Germany

- UK

- France

- Italy

- Spain

- Russia

- Netherlands

- Rest of Europe

• Asia Pacific

- China

- India

- Japan

- South Korea

- Indonesia

- Malaysia

- Australia

- Rest of APAC

• Latin America

- Argentina

- Brazil

- Mexico

- Rest of Latin America

• Middle East & Africa

- UAE

- Saudi Arabia

- Israel

- South Africa

- Rest of MEA